Upon ectopic expression, PTB-U-box enhances IGF-1R/IR ubiquitination and degradation, thereby inhibiting several key cancer hallmarks, i.e., proliferation, invasion, drug insensitivity and glucose metabolism, and thus retarding the tumor growth in xenograft. Here, INSR is linked to neoplasm.